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their metabolic activation. In the case of
acetylaminofluoro it appears that the ultimate
carcinogen is the sulphate ester of the
N-hydroxy metabolite. The dialkylnitro-
samines represent a class of chemically inert,
potent carcinogens of simple structure. The
mechanism of activation of these compounds
involves metabolic conversion to a monoalkyl
nitrosamine which spontaneously breaks
down to yield an alkyl carbonium ion. The
related nitrosamides (e.g. N-methyl-N-
nitrosourea) and nitrosamidines (e.g. MNNG)
are activated chemically by sulphydryl or
hydroxyl groups to yield carbonium ions.
The nature of the ultimate carcinogen
derived from the polycyclic hydrocarbons is
still in doubt. However, it seems likely that
an epoxide is involved and this is probably
also the case for the naturally occurring liver
carcinogen, aflatoxin.
The feature of the above and many other
mechanisms of metabolic activation is the
production of an electrophilic species which
attacks DNA. A study of the chemistry of
DNA reaction by a variety of carcinogens has
suggested that not all reactions are of equal
biological significance. In particular,
methylation of the 0-6 position of guanine,
although quantitatively a minor product of
DNA reaction, has been implicated in the
mutagenic and tumour initiating action of
methylating carcinogens.
While many gaps remain in our under-
standing of the mechanism of carcinogene3is,
the concept of DNA reaction and hence the
relationship between mutagenesis and car-
cinogenesis has proved a valuable stimulus
for further investigation.
SCREENING FOR CARCINOGENS
WITH BACTERIA. B. A. BRIDGES, MRC
Cell Mutation Unit, University of Sussex.
Bacterial systems for detecting mutagens
have been developed to a high degree of
sensitivity in recent years (e.g. Bridges et al.,
Chem-Biol. Interactions, 1972, 5, 77; Ames
et al., Proc. natn. Acad. Sci. U.S.A., 1973, 70,
782).
Since they can be used in conjunction
with mammalian microsomal preparations to
allow for metabolic activation the correlation
of mutagenicity and carcinogenicity is now
impressive (e.g. Ames et al., Proc. natn. Acad.
Sci. U.S.A., 1973, 70, 2281). Mutagens can
be broadly divided into 3 classes. The first
consists of agents which cause base pair
substitutions in DNA as a consequence of
replication errors, e.g. base analogues and
some (but not all) alkylating agents (such as
ethyl methanesulphonate and " nitrosoguani-
dine "). The second class also causes base
pair substitution mutations but they arise as
errors of repair rather than replication (e.g.
ionizing and ultra violet radiations, methyl
methanesulphonate, vinyl chloride, 7-
bromomethylbenzanthracene). Members of
the third class cause insertions or deletions of
base pairs (e.g. 2-aminofluorene). Most mem-
bers of all 3 classes are carcinogenic.
Bacterial systems can detect and differentiate
the 3 classes and predict possible carcino-
genicity. They may also detect chemicals
which damage DNA by causing cross links
but which are not particularly mutagenic
(e.g. heliotrine, mitomycin C). The carcino-
genic activity of such agents is unclear.
Bacterial systems cannot at present predict
which mammalian organs are likely to be
effected although both in vivo and in vitro
systems may be envisaged which might
enable this to be achieved.
A few carcinogens, the action of which is
based on physical properties (e.g. asbestos),
may not be detected, together with some
which are specific for the mammalian
chromosomal structure. These might be
better detected with cultured mammalian
cell systems currently under development.
A positive result in a bacterial system
should lead to an examination of the meta-
bolic fate of the chemical in mammals and
man, and possibly to full-scale tests with
laboratory animals. Bacterial tests are
likely to be most useful with industrial
chemicals, especially those already in use,
where the large numbers that need to be
tested effectively preclude animal tests
except for those particularly widely used.
CARCINOGENIC AND MUTAGENIC
ACTIVITY OF CHROMIUM CONTAIN-
ING MATERIALS. L. S. LEVY, Division
of Social Medicine and S. VENITT, Division of
Chemical Carcinogenesis, Pollards Wood
Research Station. Bucks.
Early in this century, observations oflung
cancer were made among workers in the
German bichromate producing industry.
The results were not reported until the 1930sINDUSTRIAL CARCINOGENESIS 255
but insufficient data were available for
reliable statistical evaluation. Since these
early observations, a number of thorough
epidemiological surveys, both in the U.S.A.
(Malche and Gregorious, Publ. Hlth Rep.,
1948, 63, 1114, and Great Britain (Bidstrup
and Case, Br. J. indust. Med., 1956, 13, 260)
confirmed that there indeed existed an
increased risk of workers contracting lung
cancer, but the figures for the increased risk
varied from 28 times the expected (U.S.A.) to
3 times the expected (Great Britain).
Environmental surveys conducted in the
working environment showed the atmosphere
to be contaminated with a variety oftrivalent
and hexavalent chromium materials, all of
which were therefore suspect as aetiological
factors in the lung cancer risk. However,
animal experiments, using a range of chro-
mium containing materials, yielded results
which have failed to identify unequivocally
the carcinogenic agent(s).
In collaboration with the industry in
Great Britain, we have examined a variety of
chromium containing materials for carcino-
genic activity. The materials range from
early residue mixtures to pure hexavalent
salts. We used a test system in which
stainless steel pellets, loaded with test
material using cholesterol as a carrier, are
surgically implanted into the left bronchiolus
of rat lung (Kushner et al., Proc. Third natn.
Cancer Conf., 1957, 485).
Our results show that 2 pure medium-
solubility hexavalent chromium salts induced
squamous cell carcinoma, of the lung. These
tumours were similar to those produced by
3-methylcholanthrene in the same test
system. No bronchial tumours were seen in
rats exposed to any of the intermediate
residues, highly soluble hexavalent chromate
salts orthetrivalent chromium materials.
Among non-lung tumour bearing animals,
a statistically significant increase in the
incidence ofsquamous metaplasia was seen in
all groups of rats exposed to the pure hexa-
valent chromium compounds, but not in
those exposed to the residues (all low in
hexavalent chromium) or the trivalent
chromium compounds.
The mechanism of chromate carcino-
genesis is not understood but there is con-
siderable evidence to show that a high
proportion of organic carcinogens are muta-
genic in bacteria. We have tested a number
of hexavalent and trivalent chromium com-
pounds for mutagenic activity to determine
whether this correlation holds good for
inorganic compounds. Using a mutation
assay in E. coli WP2 (Trp- -> Trp+, ochre),
we observed significant levels of induced
mutation with medium solubility and highly
soluble hexavalent chromium compounds, but
none with soluble trivalent compounds
(Venitt and Levy, Nature, Lond., 1974, 250,
493). In a more sensitive pour-plate assay
system the hexavalent chromium salts of
sodium, potassium, calcium and zinc induced
up to 20-fold increases in the yield ofmutants
and again, trivalent compounds wereinactive.
An examination of the mutagenicity of
chromates in a series of DNA-repair mutants
of E. coli WP2 indicated that chromates do
not have an absolute requirement for
" error-prone " repair for mutagenic activity
and that excision repair does not significantly
alter the mutagenic response. It is probable,
therefore, that chromates are mutagenic by
base-pair substitution in bacteria.
There is no evidence to show that the
highly soluble chromate salts such as the
chromates and biochromates of sodium or
potassium are carcinogenic in animals or
man. We have only shown carcinogenic
activity for the medium solubility calcium
chromate and zinc potassium chromate.
It is of interest to note the findings ofthe
Industrial Injuries Advisory Council (Novem-
ber 1973) on the question whether lung cancer
in workers employed in the process of manu-
facture of chromate or dichromate from
ferrous chromite ore should be prescribed
under the Industrial Injuries Act 1965.
Their conclusions, based on epidemiological
and experimental findings, including those
reported here, were that " the evidence at
this time was not such as to satisfy all the
conditions for prescription laid down by the
Industrial Injuries Act". This is because it
is not possible, by pathological methods, to
distinguish between lung cancer caused by
occupational exposure and that seen in the
general population. This shows that neither
epidemiological nor experimental studies in
themselves can always resolve questions of
legal liability associated with occupational
disease.
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